BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1796394)

  • 1. The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.
    Mitropoulos KA; Esnouf MP
    Thromb Haemost; 1991 Oct; 66(4):446-52. PubMed ID: 1796394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins.
    Mitropoulos KA; Reeves BE; Miller GJ
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):943-51. PubMed ID: 8148488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Zn2+ on the kinetic events that contribute to the 500-kDa dextran-sulfate-dependent activation of factor XII (Hageman factor).
    Loiseau C; Randriamahazaka HN; Nigretto JM
    Eur J Biochem; 1997 May; 246(1):204-10. PubMed ID: 9210485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model demonstrating different interactions of human coagulation factor XII (Hageman factor) with the surface at physiological and lower pH.
    Samuel E; Samuel M; Villanueva GB
    Biochem Mol Biol Int; 1994 Aug; 33(5):827-34. PubMed ID: 7987251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.
    Silverberg M; Diehl SV
    Biochem J; 1987 Dec; 248(3):715-20. PubMed ID: 2449171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explicit constants for the dextran-sulfate-mediated activation and autoactivation of purified human factor XII (Hageman factor).
    Loiseau C; Randriamahazaka HN; Nigretto JM
    Eur J Biochem; 1996 Aug; 239(3):692-701. PubMed ID: 8774715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of activation and autoactivation of human factor XII.
    Tankersley DL; Finlayson JS
    Biochemistry; 1984 Jan; 23(2):273-9. PubMed ID: 6607744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The surface-dependent autoactivation mechanism of factor XII.
    Røjkjaer R; Schousboe I
    Eur J Biochem; 1997 Jan; 243(1-2):160-6. PubMed ID: 9030735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.
    Samuel M; Pixley RA; Villanueva MA; Colman RW; Villanueva GB
    J Biol Chem; 1992 Sep; 267(27):19691-7. PubMed ID: 1527088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions.
    Shore JD; Day DE; Bock PE; Olson ST
    Biochemistry; 1987 Apr; 26(8):2250-8. PubMed ID: 3113477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.